Microcystin-leucine arginine promotes colorectal cancer cell proliferation by activating the PI3K/Akt/Wnt/β-catenin pathway

被引:11
作者
Tang, Yaqi [1 ]
Yi, Xiaoyu [1 ]
Zhang, Xinyu [2 ]
Liu, Baojie [1 ]
Lu, Yongzheng [1 ]
Pan, Zhifang [1 ]
Yu, Tao [1 ]
Feng, Weiguo [1 ]
机构
[1] Weifang Med Univ, Sch Life Sci & Technol, Weifang 261053, Shandong, Peoples R China
[2] Shandong First Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Tai An 271000, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
microcystin-leucine arginine; colorectal cancer; proliferation; PI3K; Akt; Wnt; beta-catenin; LR EXPOSURE; APOPTOSIS; MIGRATION; LAKE;
D O I
10.3892/or.2022.8455
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microcystin-leucine arginine (MC-LR) is an environmental toxin produced by cyanobacteria and is considered to be a potent carcinogen. However, to the best of our knowledge, the effect of MC-LR on colorectal cancer (CRC) cell proliferation has never been studied. The aim of the present study was to investigate the effect of MC-LR on CRC cell proliferation and the underlying mechanisms. Firstly, a Cell Counting Kit-8 (CCK-8) assay was conducted to determine cell viability at different concentrations, and 50 nM MC-LR was chosen for further study. Subsequently, a longer CCK-8 assay and a cell colony formation assay showed that MC-LR promoted SW620 and HT29 cell proliferation. Furthermore, western blotting analysis showed that MC-LR significantly upregulated protein expression of PI3K, p-Akt (Ser473), p-GSK3 beta (Ser9), beta-catenin, c-myc and cyclin D1, suggesting that MC-LR activated the PI3K/Akt and Wnt/beta-catenin pathways in SW620 and HT29 cells. Finally, the pathway inhibitors LY294002 and ICG001 were used to validate the role of the PI3K/Akt and Wnt/beta-catenin pathways in MC-LR-accelerated cell proliferation. The results revealed that MC-LR activated Wnt/beta-catenin through the PI3K/Akt pathway to promote cell proliferation. Taken together, these data showed that MC-LR promoted CRC cell proliferation by activating the PI3K/Akt/Wnt/beta-catenin pathway. The present study provided a novel insight into the toxicological mechanism of MC-LR.
引用
收藏
页数:8
相关论文
共 39 条
[1]   Treatment of microcystin (MC-LR) and nutrients in eutrophic water by constructed wetlands: Performance and microbial community [J].
Cheng, Rui ;
Zhu, Hui ;
Shutes, Brian ;
Yan, Baixing .
CHEMOSPHERE, 2021, 263
[2]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[3]   Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells [J].
Feng, Weiguo ;
Zhang, Meng ;
Wu, Zhuo-Xun ;
Wang, Jing-Quan ;
Dong, Xing-Duo ;
Yang, Yuqi ;
Teng, Qiu-Xu ;
Chen, Xuan-Yu ;
Cui, Qingbin ;
Yang, Dong-Hua .
FRONTIERS IN ONCOLOGY, 2020, 10
[4]   Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer Development [J].
Fujiki, Hirota ;
Suganuma, Masami .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (01) :4-18
[5]   piRNA-DQ722010 contributes to prostate hyperplasia of the male offspring mice after the maternal exposed to microcystin-leucine arginine [J].
Han, Ruitong ;
Zhang, Ling ;
Gan, Weidong ;
Fu, Kai ;
Jiang, Ke ;
Ding, Jie ;
Wu, Jiang ;
Han, Xiaodong ;
Li, Dongmei .
PROSTATE, 2019, 79 (07) :798-812
[6]   Exosomes derived from autologous dermal fibroblasts promote diabetic cutaneous wound healing through the Akt/β-catenin pathway [J].
Han, Xinye ;
Wu, Peipei ;
Li, Linli ;
Sahal, Hassan Mohamud ;
Ji, Cheng ;
Zhang, Jiahui ;
Wang, Yi ;
Wang, Qichen ;
Qian, Hui ;
Shi, Hui ;
Xu, Wenrong .
CELL CYCLE, 2021, 20 (5-6) :616-629
[7]   Molecular Pathology of Colorectal Cancer [J].
Harada, Shuko ;
Morlote, Diana .
ADVANCES IN ANATOMIC PATHOLOGY, 2020, 27 (01) :20-26
[8]   Chronic Microcystin-LR Exposure Induces Hepatocarcinogenesis via Increased Gankyrin in Vitro and in Vivo [J].
He, Lixiong ;
Huang, Yujing ;
Guo, Qiaonan ;
Zeng, Hui ;
Zheng, Chuanfen ;
Wang, Jia ;
Chen, Ji-an ;
Wang, Lingqiao ;
Shu, Weiqun .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (04) :1420-1430
[9]   WNT/β-catenin signaling in the development of liver cancers [J].
He, Shuai ;
Tang, Shilei .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
[10]   Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling [J].
He, Xiao-Shun ;
Ye, Wen-Long ;
Zhang, Yu-Juan ;
Yang, Xiao-Qin ;
Liu, Feng ;
Wang, Jing-Ru ;
Ding, Xiao-Lu ;
Yang, Yun ;
Zhang, Ruo-Nan ;
Zhao, Yuan-Yuan ;
Bi, Hai-Xia ;
Guo, Ling-Chuan ;
Gan, Wen-Juan ;
Wu, Hua .
ONCOGENE, 2022, 41 (08) :1166-1177